VNDA Cash-Secured Put Strategy

VNDA (Vanda Pharmaceuticals Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under development include HETLIOZ (tasimelteon) for the treatment of jet lag disorder, smith-magenis syndrome, pediatric Non-24, autism spectrum, and delayed sleep phase disorder; Fanapt (iloperidone) for the treatment of bipolar disorder and a long acting injectable formulation program for the treatment of schizophrenia; and Tradipitant (VLY-686), a small molecule neurokinin-1 receptor (NK-1R) antagonist, for the treatment of atopic dermatitis, gastroparesis, and motion sickness. The company's products under development also comprise VTR-297, a small molecule histone deacetylase inhibitor for the treatment of hematologic malignancies and with potential use as a treatment for various oncology indications; VQW-765, a small molecule nicotinic acetylcholine receptor partial agonist for the treatment of psychiatric disorders; a portfolio of cystic fibrosis transmembrane conductance regulator activators and inhibitors for the treatment of dry eye and ocular inflammation, as well as BPO-27 for the treatment of secretory diarrhea disorders, including cholera; and VHX-896, the active metabolite of iloperidone. It markets its products in the United States, Europe, and Israel. Vanda Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Washington, the District of Columbia.

VNDA (Vanda Pharmaceuticals Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $386.7M, a beta of 0.65 versus the broader market, a 52-week range of 3.81-9.94, average daily share volume of 2.6M, a public-listing history dating back to 2006, approximately 368 full-time employees. These structural characteristics shape how VNDA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.65 indicates VNDA has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.

What is a cash-secured put on VNDA?

A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.

Current VNDA snapshot

As of May 15, 2026, spot at $6.30, ATM IV 59.80%, IV rank 26.54%, expected move 17.14%. The cash-secured put on VNDA below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this cash-secured put structure on VNDA specifically: VNDA IV at 59.80% is on the cheap side of its 1-year range, which means a premium-selling VNDA cash-secured put collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 17.14% (roughly $1.08 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated VNDA expiries trade a higher absolute premium for lower per-day decay. Position sizing on VNDA should anchor to the underlying notional of $6.30 per share and to the trader's directional view on VNDA stock.

VNDA cash-secured put setup

The VNDA cash-secured put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With VNDA near $6.30, the first option leg uses a $5.98 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed VNDA chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 VNDA shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Sell 1Put$5.98N/A

VNDA cash-secured put risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.

VNDA cash-secured put payoff curve

Modeled P&L at expiration across a range of underlying prices for the cash-secured put on VNDA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use cash-secured put on VNDA

Cash-secured puts on VNDA earn premium while a trader waits to acquire VNDA stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning VNDA.

VNDA thesis for this cash-secured put

The market-implied 1-standard-deviation range for VNDA extends from approximately $5.22 on the downside to $7.38 on the upside. A VNDA cash-secured put lets a trader earn premium while waiting to acquire VNDA at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current VNDA IV rank near 26.54% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on VNDA at 59.80%. As a Healthcare name, VNDA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to VNDA-specific events.

VNDA cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. VNDA positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move VNDA alongside the broader basket even when VNDA-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on VNDA carry tail risk when realized volatility exceeds the implied move; review historical VNDA earnings reactions and macro stress periods before sizing. Always rebuild the position from current VNDA chain quotes before placing a trade.

Frequently asked questions

What is a cash-secured put on VNDA?
A cash-secured put on VNDA is the cash-secured put strategy applied to VNDA (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With VNDA stock trading near $6.30, the strikes shown on this page are snapped to the nearest listed VNDA chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are VNDA cash-secured put max profit and max loss calculated?
Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the VNDA cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 59.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a VNDA cash-secured put?
The breakeven for the VNDA cash-secured put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current VNDA market-implied 1-standard-deviation expected move is approximately 17.14%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a cash-secured put on VNDA?
Cash-secured puts on VNDA earn premium while a trader waits to acquire VNDA stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning VNDA.
How does current VNDA implied volatility affect this cash-secured put?
VNDA ATM IV is at 59.80% with IV rank near 26.54%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related VNDA analysis